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ed survival of transplanted cells in both normal
myocardium and myocardial scar.4-7 Cells that are
transplanted close to native cardiomyocytes develop
intercalated disks, potentially allowing communication
with host cardiomyocytes.1 Transplanted cells induce
sufficient angiogenesis to allow survival of at least
some of the donor cells. Although the mechanism of
this angiogenesis remains unclear, the survival of the
transplanted cardiomyocytes and the appearance of an
abundance of new capillaries attest to the angiogenic
potential of cell transplantation.8
Xenogeneic, allogeneic, and autologous cardiomyo-
cytes, skeletal muscle cells, and smooth muscle cells
have been successfully transplanted into normal or
injured myocardium in different species.4,6,9-12 We have
previously reported that fetal rat cardiomyocytes can
improve ventricular function after transplantation into
the myocardial scar of adult rats.4 Scorsin and col-
leagues7 also found that transplanted cells improved
R ecent studies of cell transplantation into themyocardium1-3 have suggested that transplanted
cells may replace infarcted myocardium or serve as a
platform for therapeutic gene transfer to the myocardi-
um.3,4 Either cell or gene therapy may improve postin-
farct cardiac performance. Previous studies have report-
Objective: Fetal cardiomyocyte transplantation improved heart function
after cardiac injury. However, cellular allografts were rejected despite
cyclosporine (INN: ciclosporin) therapy. We therefore evaluated autolo-
gous heart cell transplantation in an adult swine model of a myocardial
infarction. Methods: In 16 adult swine a myocardial infarction was creat-
ed by occlusion of the distal left anterior descending coronary artery by
an intraluminal coil. Four weeks after infarction, technetium 99m–ses-
tamibi single photon emission tomography showed minimal perfusion
and viability in the infarcted region. Porcine heart cells were isolated
and cultured from the interventricular septum at the time of infarction
and grown in vitro for 4 weeks. Through a left thoracotomy, either cells
(N = 8) or culture medium (N = 8) was injected into the infarct zone.
Results: Four weeks after cell transplantation, technetium 99m–sestamibi
single photon emission tomography demonstrated greater wall motion
scores in the pigs receiving transplantation than in control animals (P =
.01). Pigs receiving transplantation were more likely to have an improve-
ment in perfusion scores (P = .03). Preload recruitable stroke work (P =
.009) and end-systolic elastance (P = .02) were greater in the pigs receiv-
ing transplantation than in control animals. Scar areas were not differ-
ent, but scar thickness was greater (P = .02) in pigs receiving transplan-
tation. Cells labeled with bromodeoxyuridine in vitro could be identified
in the infarct zone 4 weeks after transplantation. Swine receiving trans-
plantation gained more weight than control animals (P = .02).
Conclusion: Autologous porcine heart cell transplantation improved
regional perfusion and global ventricular function after a myocardial
infarction. (J Thorac Cardiovasc Surg 2000;119:62-8)
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heart function after a myocardial infarction. Chiu’s
group has transplanted skeletal muscle cells into
injured canine hearts and demonstrated improved func-
tion.12,13 Taylor and colleagues14 transplanted skeletal
muscle cells into rabbit hearts with similar improve-
ment. Cell transplantation may represent a potential
therapy for postinfarction ventricular dysfunction.
Although xenotransplanted and allotransplanted cells
improved heart function, rejection led to the eventual
loss of the transplanted cells despite the use of
cyclosporine (INN: ciclosporin), and heart failure
recurred. Van Meter and colleagues10 have used a
porcine model to evaluate the survival of allogeneic and
xenogeneic implanted cells. Unfortunately, all of the
transplanted cells were destroyed by rejection. Autol-
ogous cell transplantation may therefore be the only
clinically applicable technique of cell transplantation.
To evaluate the potential benefits of autologous cell
transplantation, we transplanted cells derived from
adult pig hearts back into the same animal after cre-
ation of a myocardial infarction by occlusion of the left
anterior descending coronary artery (LAD).
Methods
Experimental animals. Adult female domestic Yorkshire
swine (35 ± 9 kg) (Charles River Canada Inc, Quebec,
Canada) were used. All procedures were approved by the
Animal Care Committee of the Toronto Hospital and per-
formed according to the “Canadian Council on Animal Care
and Use of Laboratory Animals,” published by the National
Institutes of Health.
Creation of the myocardial infarction. All surgical pro-
cedures on swine were done with the use of general anesthe-
sia and continuous electrocardiographic monitoring. Animals
were premedicated with ketamine (20-30 mg/kg, intramuscu-
larly) before induction of anesthesia with 4% isoflurane.
Anesthesia was maintained with 1% to 2.5% isoflurane.
In our initial experiments, a myocardial infarction was cre-
ated by surgical ligation of the LAD (N = 4). However,
because of concerns about the potential for postoperative
reactive inflammation and creation of epicardial collaterals,
this technique was abandoned. The subsequent pigs under-
went myocardial infarct generation by interluminal coil
occlusion and Gelfoam gelatin sponge embolization of the
distal LAD (N = 16) and only results in these animals are pre-
sented in this study.
Myocardial biopsy. A flexible bioptome was introduced in
retrograde fashion into the left ventricle from the carotid
artery under fluoroscopic guidance, and 5 biopsy specimens
were obtained from varying sites on the interventricular sep-
tum. Tissue samples were placed immediately into ice-cold
sterile cell culture dishes containing culture medium for sub-
sequent cell isolation and culture.
Cell isolation, culture, and identification. Under sterile
conditions, porcine heart cells were isolated by enzymatic
digestion, as we have previously described.15,16 The yields
from our isolation and culture procedures were evaluated by
counting the plated cells 0, 7, 14, and 28 days after isolation.
Cells were cultured for 4 weeks before transplantation.15,16
The heart cells in the culture dish were identified with the
use of monoclonal antibodies against troponin I for car-
diomyocytes, smooth muscle actin for smooth muscle cells,
and factor VIII for vascular endothelial cells, as we have pre-
viously described.11,16 Briefly, cultured cells were fixed with
100% methanol at –20°C for 20 minutes. Endogenous perox-
idase was then blocked with the use of 3% hydrogen perox-
ide for 10 minutes at 42°C and 2N HCl for 30 minutes at
room temperature. After being rinsed with phosphate-
buffered saline solution (PBS) 3 times, the cells were incu-
bated with antibodies against troponin I, smooth muscle
actin, and factor VIII in a moist chamber for 16 hours at room
temperature. Negative control samples were incubated in
PBS without the primary antibodies under the same condi-
tions. After being rinsed with PBS 3 times (15 minutes each),
the cells were then incubated with secondary antibody conju-
gated to peroxidase at 37°C for 45 minutes. The samples
were washed 3 times (15 minutes each) with PBS and then
immersed in diaminobenzidine-H2O2 (2 mg/mL diaminoben-
zidine, 0.03% H2O2 in 0.02 mL/L phosphate buffer) solution
for 15 minutes. After being washed with PBS, the samples
were covered with a crystal mount and photographed.
Cell labeling and preparation for transplantation. To
identify the transplanted cells in the recipient myocardium,
10% of the cultured myocardial cells (3 dishes out of a total
of 30 dishes for each animal, N = 3) were labeled with
bromodeoxyuridine (BrdU) (0.1 mg BrdU/mL culture medi-
um) for 2 days before transplantation. For transplantation, the
cells were dissociated from the culture dish with 0.05%
trypsin in PBS and centrifuged at 570g to remove the trypsin.
The cells were resuspended in culture medium at a concen-
tration of 107 cells/mL.
Cell transplantation. Four weeks after infarct creation,
the animals were anesthetized and the heart was exposed
through a left thoracotomy as previously described. The cell
suspension (2 mL, 2 × 107 cells) was injected into the infarct
region with a tuberculin syringe in a star pattern. One half of
the suspension was delivered into the center of the infarct,
and the remaining half was divided among 4 or 5 injections
in the periphery of the infarct zone in order to facilitate any
potential connection between the transplanted cells and the
normal myocardium. In the control pigs, only culture medi-
um, without cells, was injected into the infarct region.
Technetium 99m–sestamibi single photon emission
tomography (99mTc-MIBI SPECT). Four weeks after
infarct creation, and again 4 weeks after transplantation with
either cells or culture medium, myocardial perfusion was
assessed by injection of 10 mCi 99mTc-MIBI SPECT solution
(Dupont) 30 minutes before electrocardiogram-gated SPECT
scan acquisition, as per our standard clinical protocol.
Attenuation was calculated by determining the distance from
the detector to the center of the myocardium and counting the
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activity in venous blood samples. Two cardiologists indepen-
dently reviewed each 99mTc-MIBI SPECT scan in a blinded
fashion, performing a semiquantitative assessment of perfu-
sion and wall motion in each of 20 segments in cross-sec-
tional views at the apical and midventricular levels and in a
vertical long-axis view, as per our usual clinical protocol.
Segmental perfusion was graded as 0, 1, 2, 3, or 4, indicating
no perfusion to normal perfusion. Segmental wall motion was
graded as –1, 0, 1, 2, 3, or 4, indicating dyskinesis, akinesis,
or varying levels of hypokinesis, up to normal wall motion.
Both perfusion and wall motion were within normal limits in
all animals in the basal regions. All infarct-related scores
were obtained in 8 apical, periapical, and midventricular seg-
ments. These 8 regions contained all of the infarct areas as
assessed by pretransplant 99mTc-MIBI SPECT scans, were the
areas into which the cells were injected, and were therefore
used to assess any changes occurring with cell transplantation.
In addition, the left ventricular end-diastolic and end-systolic
volumes were measured with use of a count-based technique
and left ventricular ejection fraction calculated.
Evaluation of ventricular function by pressure-volume
loops. Four weeks after transplantation, ventricular function
in the control animals and animals receiving transplantation
was evaluated. Through a sternotomy, a conductance catheter
and a micromanometer (Millar Instruments, Inc, Austin, Tex)
were inserted into the left ventricular apex. Pressure and vol-
ume data were acquired in triplicate as well as data on real-
time pressure-volume loops constructed at baseline and dur-
ing caval occlusion. Hypertonic saline solution was injected
and measurements repeated to allow calculation of the
required compensation for parallel conductance. From the
data, the slopes of the end-systolic pressure-volume relation
and the stroke work/end-diastolic volume relation were cal-
culated in order to evaluate systolic function and myocardial
performance. Tau, or the time constant of isovolumic pres-
sure decay, was also calculated to evaluate diastolic function.
Morphologic and histologic studies. After the invasive
studies of ventricular function were complete, the heart was
arrested with potassium chloride and rapidly excised. The
atria were removed and the heart was weighed. An intraven-
tricular balloon was introduced into the left ventricle and
inflated to 30 mm Hg pressure to allow fixation in distention.
The coronary arteries were then perfused with 100 mL 10%
formaldehyde, and the heart was immersed in formaldehyde
solution for 7 days before sectioning for histologic study.
After fixation, the hearts were sliced into 5-mm–thick
slices and photographed. Cross-sectional areas of the left
ventricular muscle and scar were measured with computed
planimetry, and the endocardial-to-epicardial thickness was
measured for evaluation of ventricular remodeling.4 A cube
of tissue from the transplant site measuring 5 mm on each
side was embedded in paraffin and cut into 10-µm sections
for staining with hematoxylin and eosin, as well as with anti-
bodies against BrdU, to localize the transplanted cells.
For immunohistochemical studies, tissue slices were serial-
ly rehydrated in 100%, 95%, and 70% ethanol after deparaf-
finization with toluene. Endogenous peroxidase in the sample
was blocked and the samples were stained with antibodies
against BrdU for identification and against troponin I for con-
tractile protein as described earlier.
Statistical analysis. All data are expressed as the mean ±
SD. 99mTc-MIBI SPECT–derived perfusion and wall motion
scores were analyzed as ordinal data by χ2 analysis. 99mTc-
MIBI SPECT–derived values for left ventricular volume and
ejection fraction were subjected to 2-way analysis of vari-
ance, evaluating group, time, and group × time interactive
effects. Left ventricular pressure and volume data were sub-
jected to analysis of covariance, evaluating the effect of group
on outcomes over a range of ventricular volumes. Body
weight and other variables were assessed by t test or, when
appropriate, by 2-way analysis of variance.
Results
Cell isolation and culture. Total weight of the
myocardial biopsy specimens was 22.3 ± 1.0 mg per
animal. A mean of 1.8 ± 0.5 × 106 cells were isolated,
and the mean number of cells in culture was 10.7 ± 2.5
× 106, 53.6 ± 9.2 × 106, and 220 ± 24.8 × 106 on days
7, 14, and 28 of culture, respectively (approximately 6
to 7 doublings). Cells were cultured for 4 weeks before
transplantation to increase their number. The mixed
cell types were identified by immunocytochemistry.
Positive staining for troponin I was noted in 72% ±
14% of the cultured cells, and these cells were assumed
to be cardiomyocytes. Staining for smooth muscle actin
was observed in 5% ± 5% of the cells, and these cells
were assumed to be smooth muscle cells. Staining for
factor VIII was noted in 5% ± 5% of the cells, and these
cells were assumed to be endothelial cells. The remain-
der of the cells (18% ± 16%) were spindle shaped and
were presumed to be fibroblasts.
Activity and body weight. Four weeks after scar
generation, the swine were randomly separated into 2
groups either to receive cell transplantation (N = 8) or
to serve as controls (N = 8). During the 4 weeks after
the transplantation procedure, the animal-care techni-
cians noted a marked difference in the activity of the
animals, which appeared to correlate with the treatment
arm. The pigs receiving transplantation appeared to be
more active than control pigs, but these differences
were subjective and not easily quantifiable.
Body weight increased slightly in both groups
between the time of infarct generation and transplanta-
tion (control weight gain, 5.3 ± 0.9 kg; transplant weight
gain, 6.4 ± 1.3 kg; P = .2). The pigs receiving trans-
plantation, however, gained more weight after cell trans-
plantation than control animals (control weight gain, 7.1
± 1.7 kg; transplant weight gain, 12.6 ± 1.7 kg; P = 0.02).
Regional myocardial perfusion and wall motion
by 99mTc-MIBI SPECT. Pretransplantation and post-
transplantation 99mTc-MIBI SPECT scans were done
on each animal and results compared between times
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and between the control and transplant groups. No sig-
nificant difference in perfusion within the area of
infarction was noted between groups before transplan-
tation (P = .8). However, pigs receiving transplantation
were more likely to have an improvement in perfusion
scores than control pigs (P = .03).
Wall motion scores were not different between
groups before transplantation (P = .13). Four weeks
after transplantation, wall motion scores were signifi-
cantly greater in the pigs receiving cell transplantation
than in the control pigs (Fig 1). In control pigs, mean
wall motion scores tended to fall as the infarct zone
became increasingly dyskinetic, whereas pigs receiving
transplantation were more likely to have an improve-
ment in wall motion scores (P = .048).
Count-based scintigraphic analysis of left ventricular
ejection fractions demonstrated no difference between
groups either before transplantation (P = .66) or 4
weeks after transplantation (P = .4).
End-systolic elastance, preload-recruitable stroke
work, and tau. From the pressure-volume loops con-
structed 4 weeks after transplantation, either the pre-
load-recruitable stroke work, or the slope of the left
ventricular stroke work/end-diastolic volume index
relation (M
sw
), and end-systolic elastance, or the slope
of the end-systolic pressure-volume relation, were cal-
culated. Preload-recruitable stroke work was signifi-
cantly greater in the pigs receiving cell transplantation
than in the control pigs (transplant, 48 ± 3 mm Hg; con-
trol, 39 ± 2 mm Hg; P = .009). End-systolic elastance
was also significantly greater in the pigs receiving cell
transplantation (transplant, 5.3 ± 0.6 mm Hg · mL · m2;
control, 3.2 ± 0.7 mm Hg · mL · m2; P = .02). Tau, or
the time constant of isovolumic pressure decay, was not
different between groups (transplant, 28 ± 3; control,
26 ± 5; P = .4).
Histologic and morphometric studies. Computed
planimetric analysis indicated that the scar area in the
control group (19.6% ± 6.0% of total left ventricular
free wall) was slightly greater (P = .02) than that of
pigs in the transplant group (13.6% ± 3.5% of total left
ventricular free wall). In the center of the infarct zone,
the thickness of the scar area was significantly greater
in the pigs receiving transplantation than in the control
animals (transplant, 6.6 ± 2.8 mm; control, 3.5 ± 1.1
mm; P = .02). After the hearts were excised, the ven-
tricular volumes at 30 mm Hg distention were signifi-
cantly lower in the transplant group (42 ± 9 mL) than
in the control group (56 ± 8 mL) (P = .045).
Histologic evaluation of myocardial sections stained
with hematoxylin and eosin demonstrated greater cel-
lularity in the scar tissue of hearts from the transplant
group than in that of hearts from the control group (Fig
2). Ten percent of the cultured cells had been prela-
beled with BrdU before transplantation, and BrdU-
labeled cells were identified within the infarct zone 4
weeks after cell transplantation (Fig 3). In this model of
transplantation of autologous cells, we did not observe
any histologic evidence of rejection at 4 weeks.
Discussion
We have previously reported that allogeneic fetal rat
cardiomyocytes, when transplanted by needle injection
into the center of a cryoinjury-induced myocardial scar,
Fig 1. Regional wall motion scores, evaluated by 2 cardiologists blinded to the treatment arm, in the infarct zone
4 weeks after either cell transplantation or injection of culture medium alone. Segmental wall motion was grad-
ed as –1, 0, 1, 2, 3, or 4, indicating dyskinesis and akinesis (–1 and 0, Bad), varying levels of hypokinesis (1, 2,
and 3, Intermediate), and normal wall motion (3 and 4, Good). Wall motion scores were significantly greater in
the pigs receiving transplantation than in the control animals.
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can significantly improve ventricular function.4 In addi-
tion, we reported that allogeneic gastric-derived smooth
muscle cells also survive after transplantation into this
cryoinjured myocardial scar tissue, where they limited
ventricular dilatation after injury, possibly by restoring
myocardial elasticity.11 Smooth muscle cell transplanta-
tion also improved left ventricular function in a
Langendorff preparation. However, our present study is
Fig 2. Photomicrographs of representative sections from the infarct zones of (A) cell transplantation and (B) cul-
ture medium transplanted porcine hearts in which a LAD myocardial infarction was created. Control hearts
demonstrated predominantly fibrous scar in the infarct zone, whereas transplanted hearts had greater cellularity
(hematoxylin and eosin stain, original magnification ×400).
A B
Fig 3. Photomicrograph of a section from a porcine heart in which 10% of the cultured heart cells had been prela-
beled with BrdU in vitro before transplantation. Staining for BrdU was observed in cells throughout the infarct
zone (arrows), demonstrating some of the cells transplanted 4 weeks previously (original magnification ×400).
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the first, to our knowledge, to demonstrate that the trans-
plantation of autologous heart cells into a myocardial
infarction results in survival of the transplanted cells.
The advantage of transplanting autologous cells is the
elimination of the immunosuppressive regimen re-
quired for maintenance of allotransplants in vivo.
Histologic examination revealed no evidence of rejec-
tion at the sites of transplantation in these pigs in which
autologous cells had been harvested from the ventricu-
lar septum for expansion in culture before reimplanta-
tion. We were therefore able to avoid the confounding
effects of rejection and eventual destruction of the
transplanted cells in our evaluation of the effect of cell
transplantation on ventricular function. We believe that
autotransplantation may be the most clinically feasible
strategy by which cell transplantation may eventually
be applied to human beings.
In this experiment, we obtained a mixture of cell types
from our septal biopsy specimens and expanded these
cells in culture for 4 weeks. Before cell transplantation,
we identified these multiple cell types by immunohisto-
chemical staining for proteins specific to cardiomy-
ocytes, smooth muscle cells, and endothelial cells in
order to quantitate their relative proportions. A combi-
nation of cells consisting of cardiomyocytes, smooth
muscle cells, vascular endothelial cells, and myocardial
fibroblasts was transplanted into the infarct zone in this
series of experiments. BrdU-prelabeled cells could be
identified in the infarct zone 4 weeks after transplanta-
tion. However, because it was not possible to simultane-
ously stain for BrdU and for the cell type–specific pro-
teins in histologic sections of the hearts that received
cell transplantation, it was not possible to definitively
determine the cell type of the transplanted cells persist-
ing in the infarct zone after transplantation.
The thickness of the ventricular wall in the middle of
the scar tissue in hearts receiving transplantation was
significantly greater than that in the control hearts, and
under histologic examination this difference appeared
to be a result of increased cellularity of the infarct zone
rather than greater thickness of fibrous scar. This alter-
ation of the process of ventricular remodeling after
myocardial infarction may have been caused by
increased elasticity of the scar region and possibly by
increased formation of extracellular matrix. The thick-
er scar prevented scar expansion and limited ventricu-
lar dilatation. This conclusion was supported by our
finding that the myocardial scar area in the control
group was greater than that in the transplant group and
that the hearts receiving cell transplantation had small-
er passive left ventricular chamber volumes compared
with the control hearts. 
We did not quantitate the angiogenesis within the
infarct zone induced by heart cell transplantation.
Blood vessels were seen in the region that contained
the transplanted cells. Angiogenesis may be crucial to
the survival of the transplanted cells and may have con-
tributed to the improvement in ventricular function
noted after cell transplantation. Future studies will
quantify the capillary density and blood flow.
In this study, the load-insensitive indices of global
systolic left ventricular function were significantly
greater in the cell transplantation group than in the con-
trol animals 4 weeks after transplantation. This corre-
lated with the noninvasive evaluation of regional ven-
tricular function in the infarct zone, because the wall
motion scores (graded by 2 cardiologists blinded to the
treatment arm) were also significantly greater after cell
transplantation. We found no difference in tau, the time
constant of pressure decay during isovolumic relax-
ation, between groups. These findings contrast with
those of previous small animal studies in rats and rab-
bits in which cell transplantation has resulted primarily
in changes in diastolic function and ventricular remod-
eling.4,14 In these small animals, improvement in
indices of systolic function attributable to cell trans-
plantation has been difficult to demonstrate.
One of the limitations of the present study is the size
of the myocardial infarction generated by our coil
occlusion technique. Although the anatomy of the
porcine heart is in many ways similar to that of the
human heart, the porcine heart is very sensitive to
myocardial infarction. We noted a mortality rate of
15% with infarct creation in our current protocol. A
larger infarction would improve our ability to evaluate
the effects of cell transplantation, but the mortality rate
would also be significantly greater. We plan to use our
current porcine model to perform further, long-term
studies of the safety and efficacy of cell transplantation
to improve ventricular function in infarcted hearts.
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Discussion
Dr Ray Chu-Jeng Chiu (Montreal, Quebec, Canada). In
the abstract published for this meeting, as well as in the pre-
sentation, the authors stated that the ejection fraction was sta-
tistically significantly improved in the pigs receiving cell
implantation, in contrast to the data presented in the manu-
script, which indicated that the ejection fraction was not sta-
tistically better. If the manuscript is correct and the ejection
fraction did not differ significantly, this leads to the following
question. According to your paper, the hearts receiving cell
implantation were smaller; that is, they had statistically sig-
nificantly smaller diastolic volumes than the control hearts. If
the ejection fractions were about the same, were the stroke
volumes and the cardiac output also similar in the 2 groups,
as could be expected? If they were not different, then why
would the cell transplantation make the pigs so much happi-
er and gain more weight?
The other question is a crucial one in the minds of many of
us who are following your work with great interest. You stat-
ed that you took very small biopsy samples of the myocardi-
um and multiplied the cell number tremendously during cul-
ture before implantation. Although there was some
contamination by other types of cells, most of them, you
thought, were cardiomyocytes, and as I heard earlier in anoth-
er paper from this group, they were identified histochemically
by troponin I and myosin isoforms. However, it is generally
believed that normal mature cardiomyocytes are terminally
differentiated cells, and they do not divide in vivo. Therefore
their phenotype must have been changed if in fact somehow
you were able to make them proliferate in the culture. When
normally nondividing cells are converted into a cell line and
immortalized in vitro, there is always the concern of onco-
genicity in vivo. Therefore my question is, what evidence do
you have that the modified cardiomyocytes are safe for
implantation in patients without the risk of malignancy?
Dr Li. In these experiments, the cells isolated from our
myocardial biopsy samples proliferated in vitro. Although the
cells did not have sarcomeres, immunohistochemical staining
with antibodies against troponin I and myosin heavy chains
showed that most of the cultured cells contained these con-
tractile proteins. Our previous study (Cardiovasc Res
1996;32:362-73) demonstrated that the intracellular content
of these contractile proteins progressively decreased while
the cells were maintained in culture for 3 months. Therefore,
the cells, we believe, are dedifferentiated cardiac muscle cells.
In the study we reported today, the cells were stained with
antibodies against contractile proteins before transplantation.
Most of the cells contained these contractile proteins and
were subsequently transplanted into the infarct zone, where
they survived for the 4-week duration of our study.
We were also concerned about continuing cellular prolifer-
ation after transplantation. Therefore we evaluated trans-
planted cell proliferation in vivo in a long-term study (3
months) (Circ Res 1996;78:283-8). Cultured heart cells were
implanted into the subcutaneous tissue of an adult rat. Cell
proliferation was evaluated with the use of BrdU labeling,
and echocardiography was used to measure the growth of the
transplanted tissue. We found that the cells proliferated only
in vitro, and not in vivo. After transplantation the cells under-
went hypertrophy but no further division. No BrdU uptake
was detected in the implanted cells.
In response to your question about heart function, we
encountered some difficulty with our porcine infarct model. In
the first group of animals we studied by 99mTc-MIBI SPECT
scanning, we found that the control animals had a decrease in
ejection fraction and cardiac output after media transplanta-
tion and the infarct area thinned and dilated after 4 weeks. In
the animals that received transplantation with heart cells, the
infarct region did not thin or dilate and the ejection fraction
and cardiac output were well preserved. This information
formed the basis of our abstract. We then did additional ani-
mal studies. In the control group we found a consistent thin-
ning and dilatation of the infarction region by morphometric
examination. However, the hemodynamic response, as mea-
sured by 99mTc-MIBI SPECT scans, did not show a consistent
decrease in either ejection fraction or cardiac output.
In our final analysis, we did not find a difference in the
ejection fraction between the transplant and control groups,
but we did find a difference in load-independent indices of
function, scar thickness, chamber volume, and weight gain.
We believe that heart cell transplantation altered the remod-
eling process after a myocardial infarction and permitted
better cardiac function than that of the control animals.
